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Gingivitis and periodontitis are chronic bacterial diseases of the underlying and surrounding tooth tissues. Diabetes mellitus is
responsible for tooth deprivation both by decay and periodontal disease. The streptozotocin-induced diabetes results in a diabetic
status in experimental animals similar to that observed in diabetes patients. The aim of the study was to investigate the relationship
between the gingival lesions and the microangiopathy changes in streptozotocin-induced diabetes mellitus. Forty male Wistar rats
were divided into two groups (control and experimental). Diabetes mellitus was induced by 45mg/kg IV streptozotocin. The
histological investigation of the marginal gingival and the relevant gingival papilla showed inﬂammation of the lamina propria
and the squamous epithelium as well as marked thickness of the arteriole in the diabetic group, but no changes were observed in
the control group. The results suggested a probable application of a routine gingival histological investigation in diabetic patients
in order to control the progress of disease complications. It may be concluded that histological gingival investigation can be used
as a routine assay for the control of the diabetic disease and prevention of its complications.
Copyright © 2009 C. Tesseromatis et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
Gingivitis and periodontitis are chronic bacterial diseases of
theunderlyingandsurroundingtoothtissues.Theinitialfac-
tor in the development of the periodontal disease is the host
response and its defense capacity to the microbial stimuli.
Systemic factors modify all forms of gingivitis and periodon-
titis through their eﬀect on the physiological immune and
inﬂammatory defense. It has been reported [1] that nerve
ﬁbers are involved in the neurogenic inﬂammation induced
by mechanical or chemical irritations in the gingival and the
underlying tissues. It has also been suggested that in diabetes
mellitusthe unmyelinated smalldiameter ﬁbersare impaired
asaresultofdiabeticneuropathy.Furthermore,manystudies
have been focused in the impairment of bone mass, occur-
ring in diabetes mellitus. Microangiopathy at the bone tissue
was suggested as a possible cause of diabetic osteopenia [2].
Diabetes can have an impact on the bone through multiple
pathways, some with contradictory eﬀects, including obesity,
changes in insulin levels, higher concentrations of advanced
glycation end products in collagen, hypercalciuria associated
with glycosuria, reduced renal function, lower insulin-like
growth factor-I, microangiopathy, and inﬂammation [3].
Furthermore, diabetes mellitus is responsible for tooth
deprivation both by decay and periodontal disease. Systemic
diseases are associated with a higher experience of caries,
a high ratio of decayed-to-present teeth, and more gingival
andperiodontalproblems.Patientswithhighbloodpressure,
osteoporosis or diabetes mellitus tended to have poorer gin-
gival or periodontal conditions, fewer teeth, and higher risk
of edentulousness [4]. In addition, it was found that a larger
number of oral streptococci adhered to the tooth surfaces are
observed in nonobese diabetogenic mice that spontaneously
develop insulin-dependent diabetes mellitus [5].
The aim of the study was to investigate the relation-




Figure 1: () Focal perivascular and diﬀuse inﬂammation of the
lamina propria, (↑) neo-angiogenesis, and (∗) hyperplasia of the
squamous epithelium.
presence of microangiopathy in streptozotocin-induced dia-
betes mellitus.
2.MaterialandMethods
Forty male Wistar rats of average body weight of 200g were
divided into groups A (experimental n = 20) and B (control,
n = 10). They were housed ﬁve per cage at a constant room
temperature (22 ± 1◦C) under a 12-hour light/12-hour dark
(light period 00.8–20.00 hours) cycle. Food and water were
provided ad libitum. Animals were cared for accordance
with the principles of the “Guide for the Care and Use of
Experimental Animals” [6] .T h ea n i m a l so fg r o u pAw e r e
injected once IV with streptozotocin 45mg/kg in the jugular
interna. The duration of the experiment was 90 days. The
blood glucose levels were estimated every week with wash-
oﬀ strips (Dextrostix, Ames Division, Miles Laboratories,
Rexdale, Ontario, Canada) in blood obtained from the tail
vessels. In parallel, glucose was also qualitatively assayed
in urine with urineteststrips (Glukotest Accu-test Roche).
The animals’ body weight as well as their food intake was
determined. The animals were sacriﬁced by decapitation,
and gingiva specimens obtained from the incisor area of the
mandible were washed with water and then conserved in
10% formalin solution for further histological examination
with the light microscope. The histological slices of gingival
specimens were stained with haematoxylin-eosin by light
microscope. The values were expressed as mean ± standard
deviation (m ± SD). The statistical analysis was performed
by Student’s t-test and by x2 analysis. P<. 05 was considered
as an acceptable level of signiﬁcance.
3. Results
The induction of diabetes mellitus was assessed the day after
streptozotocin injection by evaluating clinical symptoms
such as frequent urination, increased appetite, and weight
loss. In comparison to the control group, the experimen-
tal animals exerted a hyperphagia accompanied with an
increaseddailyfoodconsumption.Furthermore,thestrepto-




Figure 2: (∗) Hyperplasia of the squamous epithelium, ()d i ﬀuse
and perivascular inﬂammation of the lamina propria, and (↑)
thickening of the wall of some arterioles.




Daily food intake (g) 14,86 ± 5,09 19,25 ± 0,95∗∗
Body weight (sacriﬁce
day) g
190 ± 17 160 ± 20∗∗
Hb A1c (%) 5,5% 8,2 ± 1,4%∗∗
Serum glucose mg/dL 90 250∗∗
∗∗P<,001 versus control.
Table 2: Histological ﬁndings.
Margin gingival incisor area Diabetes mellitus Control
Inﬂammation +++ +
Neoangiogenesis +++ +
Vessel wall thickness +++ +
Buccal/lingal gingiva
Hyperkeratosis +++ +
Epithelium hypertrophy ++ —
glycosylated haemoglobin (Hb A1c) levels. The severity
of diabetes was indicated by the statistically signiﬁcantly
decreased body weight in the experimental animals in com-
parison to controls P<,001 (Table 1). The quantity of daily
food intake was increased in diabetic animals compared to
controls. Blood glucose levels were signiﬁcantly increased in
the experimental group (Table 1). The levels of Hb A1c were
lower in the control compared to the experimental group.
The urination of the experimental group was frequent and
the shavings of the cages needed to be changed twice daily.
The experimental animals had a mortality of 10% during
the experimental period, while all the control animals
remained alive until the end of the experimental procedure.
The histological ﬁndings of the experimental group were
as follows. Through haematoxylin-eosin stain, the biopsies
from the marginal gingivae and the gingival papillae from
the incisor area showed inﬂammation of the lamina propria,
formation of new vessels with various wall thicknesses, andInternational Journal of Dentistry 3
100μm
∗
Figure 3: (∗) Normal gingival mucosa. normal squamous epithe-
lium,(↑)normalpropriavasculature, andabsenceofinﬂammation.
hyperaemia. This alteration was localized in the internal site
of the gingiva, which was in contact with the tooth surface.
The gingival specimens obtained from the molar area
of the mandible of the buccal and lingual sites showed
moderate to high hyperceratosis and mild inﬂammation.
All the experimental animals showed moderate-to-severe
angiitis, which was not observed in the control animals (see
Table 2, Figures 1 and 2).
4. Discussion
Recent drastic increase in diabetic population poses seri-
ous problems in both health sciences and socioeconomic
services. The recent drastic increase in the diabetic popu-
lation poses serious problems in both health sciences and
socioeconomic services. The most important issue in the
clinical management of diabetic patients is the chronic
complications that contribute to a high morbidity and
mortality [7, 8].
Hyperglycaemia, as a common feature of diabetes melli-
tus, is a cause of diﬀerent pathogenic mechanisms inﬂuenc-
ing endothelial function.
Diabetes mellitus results in the development of large and
micro-vessel damage. A series of changes occur indepen-
dently of the presence of atherosclerosis. The abnormalities
include accumulation of PAS-positive material, laminin,
ﬁbronectin, type IV collagen, and connective tissue with lack
of acid mucopolysaccharides, and deposition of calcium. It
is of particular interest that accumulation of PAS-positive
material and lack of acid mucopolysaccharides are recog-
nizedasthehistologicalmarkersofdiabeticmicroangiopathy
[2, 8–12].
In this study, the administration of streptozotocin in
rats induced a diabetic status in the experimental animals
similar to that observed in diabetic patients, as shown by the
manifested clinical symptoms in accordance with previously
reported literature [2, 13, 14].
The changes observed in bed vasculature concerned
macro- and microangiopathy. The extention of microan-
giopathy is known to impair the function of various organs
and systems and common problems are manifested as
retinopathy, nephropathy, and neuropathy [15]. Periodontal
disease is considered as the sixth complication of diabetes
mellitus. It has long been observed that diabetic patients
have greater tooth loss due to periodontal disease than
nondiabetics of comparable age [16]. The severity of the
periodontal disease is absolutely inﬂuenced by the degree of
diabetic status [17]. The phenomenon may be due to the
high tissue glucose concentration, as well as to the presence
of metabolic products of the impaired glucose metabolism
and it is recognized histologically as enlarged vessel wall
with a narrowing of vessel lumen diameter. This process
induces disabilities of vessel wall and, in general, leads to
abnormal vasculature [12, 18]. Our results are in agreement
with those of other investigators, who reported narrowing of
vessel lumen diameter in diabetic subjects as observed by the
increased uptake of PAS deposition in the vessel walls [9].
These changes can be aggravated through inﬂammatory
cell inﬁltration that occurs after one week of steptozotocin
treatment in the gingivomucosal tissue as reported by Feh´ er
et al. [1]. Despite multiple and long-term studies, the patho-
physiology of diabetic microangiopathy and its pathogenesis
are not fully elucidated. Under chronic hyperglycemia, early
stimuli elicit adaptive reactions of tissues showing acute
inﬂammatory processes of vessel walls and changes of
microangiopathy.Theimpairedglucosemetabolismisrecog-
nized histologically as enlarged vessel wall with a narrowing
of vessel lumen diameter. This situation in dental care can
be recognized by delay healing of tooth extraction sockets,
periradical lesions, and periodontal disease [4, 19, 20].
In addition, it has been suggested that the unmyelinated
small-diameter aﬀerent nociceptive C-ﬁbers are impaired in
diabetes mellitus, which indicates that in the streptosotocin-
induced diabetic rat, gingivomucosal tissue is the prerequi-
site for neurogenic inﬂammation induced by mechanical or
chemical irritations causing a pronounced vessel permeabil-
ity. Furthermore, diabetic changes may be accompanied by
decreased collagen production in rat periodontal tissue [21].
This process induces disabilities of vessel wall such as
narrowed vessel calibre and in general leads to the formation
of an abnormal vasculature [12, 19]. Since the ability of the
diabetic’scirculationtodistributebloodisaﬀected,especially
during increased blood ﬂow causing severe disturbances, the
surrounding and underlying tooth tissues have poor nour-
ishment, which, in relation to the high blood glucose levels,
promotes the colonization of overdeveloped microﬂora in
the oral cavity [22]. The presence of PAS material deposition
in gingival vessel can be considered as an index of severe
diabetic damage [9]. Therefore, slow ﬂow of nutrients and
high infection liability promote the destruction process of
the periodondium [23].
An important injury that leads to severe handicap in
diabetic patients is the development of retinopathy that
usually leads to blindness [24]. Most recently, it has been
proven that the risk of proliferative diabetic retinopathy was
higher in the presence of the periodontal disease [25]. In
addition, the occurrence of neuropathy in long-term type 2
diabetes is related to tooth loss and tempomandibular joint
disfunction [26].
Therefore, the investigation of the surrounding oral
cavity tissues in diabetic patients can demonstrate changes
or signs that may alert the physician to control or prevent the4 International Journal of Dentistry
development of diabetes mellitus. Furthermore, histological
gingival analysis may be routinely utilized for the control
of the diabetic disease and perhaps may be considered as a
diagnostic method of the severity of the disease.
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